{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:24:28Z","timestamp":1778617468974,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA046100"],"award-info":[{"award-number":["DA046100"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI122390"],"award-info":[{"award-number":["AI122390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI120898"],"award-info":[{"award-number":["AI120898"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ymthe.2020.05.018","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T05:17:00Z","timestamp":1589951820000},"page":"1795-1805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Thomas D.","family":"Norton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Leibowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Homann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel R.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.05.018_bib1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12026-017-8931-1","article-title":"Dendritic cell-based immunotherapy: a basic review and recent advances","volume":"65","author":"Constantino","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ymthe.2020.05.018_bib2","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/ijms17121985","article-title":"Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis","volume":"17","author":"Coelho","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2020.05.018_bib3","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4161\/hv.25876","article-title":"Dendritic cell based vaccines for HIV infection: the way ahead","volume":"9","author":"Garc\u00eda","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2020.05.018_bib4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00262-012-1242-4","article-title":"Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial","volume":"61","author":"Ellebaek","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2020.05.018_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/gt.2014.117","article-title":"Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in\u00a0vitro","volume":"22","author":"Norton","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.05.018_bib6","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI200317098","article-title":"In\u00a0vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T\u00a0cell responses","volume":"111","author":"Esslinger","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.05.018_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature10623","article-title":"HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase","volume":"480","author":"Goldstone","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.05.018_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.05.018_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.05.018_bib11","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1128\/JVI.00346-11","article-title":"Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells","volume":"85","author":"Sunseri","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/gt.2012.61","article-title":"Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein","volume":"20","author":"Bobadilla","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2020.05.018_bib13","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ymthe.2019.03.008","article-title":"Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice","volume":"27","author":"Norton","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.05.018_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib15","doi-asserted-by":"crossref","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T\u00a0cells is linked to antigen recognition and T\u00a0cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2020.05.018_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib18","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib20","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1470-2045(17)30065-7","article-title":"Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial","volume":"18","author":"Sharma","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.05.018_bib24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T\u00a0cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2020.05.018_bib25","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1172\/JCI26856","article-title":"Reprogramming of antiviral T\u00a0cells prevents inactivation and restores T\u00a0cell activity during persistent viral infection","volume":"116","author":"Brooks","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.05.018_bib27","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic Cell-Based Immunotherapy: State of the Art and Beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2020.05.018_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2017.05.006","article-title":"Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape","volume":"38","author":"Garg","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2018.00610","article-title":"Combination Immunotherapy: Taking Cancer Vaccines to the Next Level","volume":"9","author":"Grenier","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.celrep.2013.07.037","article-title":"Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response","volume":"4","author":"Behrendt","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2020.05.018_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/v11020156","article-title":"Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus","volume":"11","author":"Kahan","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2020.05.018_bib32","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T\u00a0cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.05.018_bib33","doi-asserted-by":"crossref","first-page":"21182","DOI":"10.1073\/pnas.1118450109","article-title":"Antigen-specific CD4 T-cell help rescues exhausted CD8 T\u00a0cells during chronic viral infection","volume":"108","author":"Aubert","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.05.018_bib34","doi-asserted-by":"crossref","first-page":"97ra79","DOI":"10.1126\/scitranslmed.3002715","article-title":"Long-term persistence of a polyclonal T\u00a0cell repertoire after gene therapy for X-linked severe combined immunodeficiency","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib35","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2020.05.018_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jgm.400","article-title":"Lentivirally transduced dendritic cells as a tool for cancer immunotherapy","volume":"5","author":"Breckpot","year":"2003","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002371-200309000-00008","article-title":"Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery","volume":"26","author":"Koya","year":"2003","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2020.05.018_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.20071949","article-title":"Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection","volume":"205","author":"Ha","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib40","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.4049\/jimmunol.180.11.7553","article-title":"PDL-1 blockade impedes T\u00a0cell expansion and protective immunity primed by attenuated Listeria monocytogenes","volume":"180","author":"Rowe","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib41","doi-asserted-by":"crossref","first-page":"e02035-18","DOI":"10.1128\/JVI.02035-18","article-title":"Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions","volume":"93","author":"Garcia-Bates","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.05.018_bib42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1257","article-title":"Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination","volume":"11","author":"Badovinac","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.05.018_bib43","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","article-title":"Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome","volume":"92","author":"Seyama","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2020.05.018_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620302525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620302525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:05:04Z","timestamp":1778616304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620302525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1525001620302525"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.05.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}